Generation of antibodies specific for β-amyloid by vaccination of patients with Alzheimer disease
Hock C, Konietzko U, Papassotiropoulos A, et al: Generation of antibodies specific for β-amyloid by vaccination of patients with Alzheimer disease. Nat Med 2002; 8: 1270-1275
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
DeMattos RB, Bales KR, Cummins DJ, et al: Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2001; 98: 8850-8855
Increased T cell reactivity to amyloid β protein in older humans and patients with Alzheimer disease
Monsonego A, Zota V, Karni A, et al: Increased T cell reactivity to amyloid β protein in older humans and patients with Alzheimer disease. J Clin Invest 2003; 112: 415-422
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk D, Barbour R, Dunn W, et al: Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999; 400: 173-177
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
Gilman S, Koller M, Black RS, et al: Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial. Neurology 2005; 64: 1553-1562
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: A case report
Nicoll JAR, Wilkinson D, Holmes C, et al: Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nat Med 2003; 9: 448-452
Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
Bard F, Cannon C, Barbour R, et al: Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 2000; 6: 916-919
Development of a safe oral Aβ vaccine using recombinant adeno-associated virus vector for Alzheimer's disease
Hara H, Monsonego A, Yuasa K, et al: Development of a safe oral Aβ vaccine using recombinant adeno-associated virus vector for Alzheimer's disease. J Alz Dis 2004; 5: 483-488